Zobrazeno 1 - 10
of 11
pro vyhledávání: '"de Vera Mudry MC"'
Autor:
Patel S; School of Microbiology and APC Microbiome Ireland, University College Cork, Cork, Ireland.; SeqBiome Ltd, Cork, Ireland., Becker E; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Ploix C; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Steiner G; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Scepanovic P; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Fueth M; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., de Vera Mudry MC; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Eichinger-Chapelon A; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Marrer-Berger E; Pharmaceutical Sciences, Roche Innovation Center Basel, Pharma Research & Early Development, Hoffmann-La Roche, Basel, Switzerland., Claesson MJ; School of Microbiology and APC Microbiome Ireland, University College Cork, Cork, Ireland.; SeqBiome Ltd, Cork, Ireland.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2023 Dec 01; Vol. 7 (12), pp. 872-885.
Autor:
Wildum S; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Korolowicz KE; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Suresh M; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Steiner G; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Dai L; Roche Pharma, Research and Early Development, Roche Innovation Center Shanghai, Shanghai, China., Li B; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Yon C; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., De Vera Mudry MC; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Regenass-Lechner F; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Huang X; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Hong X; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Murreddu MG; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States., Kallakury BV; Department of Pathology, Georgetown University Medical Center, Washington, DC, United States., Young JAT; Roche Pharma, Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Menne S; Department of Microbiology and Immunology, Georgetown University Medical Center, Washington, DC, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 May 23; Vol. 13, pp. 884113. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022).
Autor:
De Vera Mudry MC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 1529F. Hoffmann-La Roche Ltd, Basel, Switzerland., Martin J; 1529Roche Tissue Diagnostics, Santa Clara, CA, USA., Schumacher V; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 1529F. Hoffmann-La Roche Ltd, Basel, Switzerland., Venugopal R; 1529Roche Tissue Diagnostics, Santa Clara, CA, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2021 Jun; Vol. 49 (4), pp. 851-861. Date of Electronic Publication: 2020 Dec 29.
Autor:
Parrula C; Preclinical Safety Evaluation, 2184Vertex Pharmaceuticals Incorporated, Boston, MA, USA., Dincer Z; Pathology, 63899Covance Laboratories Limited, Harrogate, United Kingdom., Geoly FJ; 105623Worldwide Research & Development, Pfizer Inc, Groton, CT, USA., De Vera Mudry MC; 1529Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Mysore J; Drug Safety Evaluation, 3971Bristol-Myers Squibb, New Brunswick, NJ, USA., Wuersch K; PreClinical Safety, 98560Novartis AG, Basel, Switzerland.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2020 Dec; Vol. 48 (8), pp. 939-943. Date of Electronic Publication: 2020 Nov 28.
Autor:
Klein C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Waldhauer I; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Nicolini VG; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Freimoser-Grundschober A; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Nayak T; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Vugts DJ; Roche Pharma Research & Early Development, Department of Radiology & Nuclear Medicine, VU University Medical Center , Amsterdam, the Netherlands., Dunn C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Bolijn M; Roche Pharma Research & Early Development, Department of Radiology & Nuclear Medicine, VU University Medical Center , Amsterdam, the Netherlands., Benz J; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Stihle M; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Lang S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Roemmele M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Hofer T; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., van Puijenbroek E; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Wittig D; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Moser S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Ast O; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Brünker P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Gorr IH; Roche Pharma Research & Early Development, Roche Innovation Center Munich , Penzberg, Germany., Neumann S; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., de Vera Mudry MC; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Hinton H; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Crameri F; Roche Pharma Research & Early Development, Roche Innovation Center Basel , Basel, Switzerland., Saro J; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Evers S; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Gerdes C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Bacac M; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., van Dongen G; Roche Pharma Research & Early Development, Department of Radiology & Nuclear Medicine, VU University Medical Center , Amsterdam, the Netherlands., Moessner E; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland., Umaña P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich , Schlieren, Switzerland.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2017 Jan 11; Vol. 6 (3), pp. e1277306. Date of Electronic Publication: 2017 Jan 11 (Print Publication: 2017).
Autor:
Bogman K; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B). katrijn.bogman@roche.com., Schwab D; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Delporte ML; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Palermo G; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Amrein K; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Mohr S; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., De Vera Mudry MC; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Brown MJ; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B)., Ferber P; From the Clinical Pharmacology (K.B., D.S., M.-L.D.), Biostatistics (G.P.), Discovery (K.A.), Pharmaceutical Sciences (S.M., M.C.D.V.M.), and Translational Medicine, Cardiovascular Diseases (P.F.), Pharma Research and Early Development, Roche Innovation Center Basel, Switzerland; and Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, United Kingdom (M.J.B).
Publikováno v:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2017 Jan; Vol. 69 (1), pp. 189-196. Date of Electronic Publication: 2016 Nov 21.
Autor:
Bessa J; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Meyer CA; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., de Vera Mudry MC; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Schlicht S; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Smith SH; Stiefel, a GSK Company, Center for Skin Biology, 20 T.W. Alexander Dr., Research Triangle Park, NC 27709, USA., Iglesias A; F. Hoffmann-La Roche Ltd, pRED, Pharma Research and Early Development, Grenzacherstrasse 124, CH-4070 Basel, Switzerland., Cote-Sierra J; Hoffmann-La Roche Inc., pRED, Pharma Research and Early Development, Nutley, NJ, USA. Electronic address: Javier.x.cote-sierra@stiefel.com.
Publikováno v:
Journal of autoimmunity [J Autoimmun] 2014 Dec; Vol. 55, pp. 33-41. Date of Electronic Publication: 2014 Apr 29.
Autor:
De Vera Mudry MC; Department of Non-Clinical Drug Safety, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Kronenberg S, Komatsu S, Aguirre GD
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2013 Aug; Vol. 41 (6), pp. 813-25. Date of Electronic Publication: 2012 Dec 27.
Autor:
de Vera Mudry MC; Non-Clinical Safety, Pharma Research and Early Development, F. Hoffmann-La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland., Regenass-Lechner F, Ozmen L, Altmann B, Festag M, Singer T, Müller L, Jacobsen H, Flohr A
Publikováno v:
International journal of Alzheimer's disease [Int J Alzheimers Dis] 2012; Vol. 2012, pp. 289412. Date of Electronic Publication: 2012 Dec 17.
Autor:
Mikaelian I; Non-Clinical Safety, Bldg 100/310, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110, USA. igor.mikaelian@roche.com, Buness A, de Vera-Mudry MC, Kanwal C, Coluccio D, Rasmussen E, Char HW, Carvajal V, Hilton H, Funk J, Hoflack JC, Fielden M, Herting F, Dunn M, Suter-Dick L
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2010 Sep; Vol. 117 (1), pp. 144-51. Date of Electronic Publication: 2010 Jul 12.